2021 COMPUTEX Forum Day 2: Unlocking Next-Generation Technologies
4.6.2021 13:03:00 EEST | Business Wire | Press release
The second day of COMPUTEX Forum, organized by TAITRA, featured "Critical Technology" and "Tomorrow Tech." World-renown tech leaders such as Qualcomm, QCT, WIN Semiconductors Corp., Siemens, Far EasTone Telecom, NVIDIA, and IBM shared their perspectives on the latest development of 5G, AI & IoT, and quantum computing, as well as their strategies for navigating in the new normal.
Cynthia Kiang, Director General of the Bureau of Foreign Trade, MOEA, Taiwan, said in her opening remarks that the recent global chip shortage underscores the importance of supply chain resilience, and that international cooperation is the best way to ensure supply chain efficiency and stability. She expects COMPUTEX to be a platform that helps with integrating global resources, allowing ecosystem partners to explore future business opportunities.
Qualcomm: Empowering the future of PC with mobile computing
With the onset of the pandemic and shift to remote working and learning, the way people use PCs has rapidly expanded. Alex Katouzian, Senior Vice President and General Manager of Mobile, Compute, and Infrastructure for Qualcomm Technologies, shared his unique perspectives on how 5G along with always connected PC are facilitating connectivity, mobility, and productivity as PC becomes the best collaborative tool in a mobile office. Qualcomm will also continue to collaborate with its ecosystem partners to realize the future of always connected PC.
QCT: 5G New Era: Great Convergence, Broad Ecosystem, Golden Opportunity
Mike Yang, President of QCT, talks about the great convergence of IT and CT, and the many new entrants into the Telco ecosystem that are changing our daily lives. With them more and more service providers will push for digital transformation and build 5G networks that will open up new opportunities for everyone, including operators and enterprises.
WIN Semiconductors Corp: Shaping the future with compound semiconductors
Dr. Yu-Chi (YC) Wang, Vice Chairman of WIN Semiconductors Corp emphasized that compound semiconductors are essential in realizing a life style built on seamless connection, precise sensing, and efficiency power. In addition, future life will be based on ubiquitous AI access with 6G, super IoT, and AI. Compound semiconductor will play a pivotal role to advance that future.
Siemens: Industrial 5G, Grid Edge and Connected Mobility will accelerate smart economy development and drive industrial innovation and transformation
Taiwan is crucial in the global supply chain of ICT components with a comprehensive industrial value chain. Erdal Elver, President and CEO of Siemens Taiwan pointed out that Taiwan has a clear advantage in introducing 5G innovative applications in manufacturing and city infrastructure. Siemens’ world-leading technologies and success stories in Industrial 5G, Grid Edge and Connected Mobility will assist Taiwan in ushering in application innovation in a variety of fields, helping Taiwan move toward its vision of "Digital Nation, Smart Island."
Far EasTone Telecom: Enabling clinical intelligence through telemedicine with 5G, IoT, big data, and AI
Chee Ching, President of Far EasTone Telecom, discussed medical applications in the 5G era. Telemedicine supported by 5G is capable of diagnosing patients remotely through features such as high resolution, big bandwidth, low latency, and massive connectivity. Telemedicine will also be able to detect and prevent diseases using big data and AIoT, ushering a new era of smart medicine. Chee Ching also pointed out that long-term care will be the extended application field for telehealth. With Taiwan expected to become a super-aged society by 2026, Far EasTone Telecom views this not only as a business opportunity but also as a social responsibility.
NVIDIA: Empowering collaboration across shared virtual worlds by addressing 3D workflows
Richard Kerris, NVIDIA Head of Worldwide Developer Relations and General Manager of Omniverse, indicated that a distributed workforce has become the norm with the rise of hybrid work. Remote working, however, has deepened the challenges of 3D workflows. NVIDIA Omniverse, the revolutionary new platform for virtual collaboration and simulation, can empower individuals and companies across multiple industries to address the challenges of complex 3D workflows by connecting users, content creation tools, and enabling AI to be used across shared virtual worlds.
IBM: Quantum computing
Norishige Morimoto, Vice President of IBM Research and Development of Japan, stated that quantum computing has yet to overcome obstacles on hardware and application development before becoming available for all. Now, IBM is collaborating with industry and universities including NTU, focusing on finance, chemistry, material industries.
2021 COMPUTEX Forum and keynote speeches are all available for viewing on #COMPUTEXVirtual online platform and COMPUTEX YouTube channel from now.
For more information:
COMPUTEX : https://www.computextaipei.com.tw/
InnoVEX : https://www.innovex.com.tw/
About COMPUTEX
Established in 1981, COMPUTEX is one of the leading global ICT, IoT, and startup tradeshows with a complete supply chain and IoT ecosystems. Co-organized by the Taiwan External Trade Development Council (TAITRA) and Taipei Computer Association (TCA), COMPUTEX, based upon Taiwan’s complete ICT clusters, covers the whole spectrum of the ICT industry, from established brands to startups and from ICT supply chain to IoT ecosystems. With strong R&D and manufacturing capabilities and IPR protection, Taiwan is a strategic destination for foreign companies and investors looking for partners in global technology ecosystems. Follow COMPUTEX on its website at www.computextaipei.com.tw and Twitter @computex_taipei using the hashtag #COMPUTEX.
About COMPUTEX 2021 Virtual
As a pioneer in technology, COMPUTEX has been at the forefront in embracing digital transformation. In 2021, the show will go online. Together with the key global technology players, the organizer of COMPUTEX,Taiwan External Trade Development Council (TAITRA) introduces #COMPUTEXVirtual (including its global startups and innovations showcase #InnovexVirtual), an AI-driven virtual platform, and aims to deliver an exceptional virtual exhibition experience beyond the distance.
Explore #COMPUTEXVirtual now at https://virtual.computextaipei.com.tw/.
About TAITRA
Founded in 1970, TAITRA is Taiwan's foremost nonprofit trade promoting organization. Sponsored by the government and industry organizations, TAITRA assists enterprises to expand their global reach. Headquartered in Taipei, TAITRA has a team of 1,300 specialists and operates 5 local offices in Taoyuan, Hsinchu, Taichung, Tainan and Kaohsiung, as well as 63 branches worldwide. Together with Taipei World Trade Center (TWTC) and Taiwan Trade Center (TTC), TAITRA has formed a global network dedicated to promoting world trade.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210604005260/en/
Contact information
Press:
Ms. Tessa Lin <tessalin@taitra.org.tw>
Ms. Li Chao < lichao@taitra.org.tw>
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Two-Year Data of Pimicotinib Demonstrated Durable Tumor Control and Sustained Improvement in TGCT Symptoms and Joint Function26.10.2026 13:00:00 EET | Press release
Merck, a leading science and technology company, today announced new two-year follow-up results from the Phase 3 MANEUVER study evaluating pimicotinib in patients with tenosynovial giant cell tumor (TGCT). The study showed that among patients initially randomized to pimicotinib, improvements in symptoms and joint function were observed as early as Week 5, sustained through two years, and continued to improve over time. Tumor responses remained robust1 and durable,2 and the safety profile was consistent with previous analyses. The findings are being presented today in the Sarcoma poster session at the European Society for Medical Oncology (ESMO) Congress 2026 (Presentation # 3747P). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022786567/en/ David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck "For people living with TGCT, the impact of the disease is often felt through persis
WHOOP and Samuel Ross MBE Unveil Layer 2 of PROJECT TERRAIN26.10.2026 12:30:00 EET | Press release
WHOOP, the human performance brand, today announced Layer 2 of PROJECT TERRAIN, its multiyear collaboration with British designer Samuel Ross MBE and his design atelier, SR_A. Building on the sold out debut collection launched in March 2026, Layer 2 expands PROJECT TERRAIN to its next season connecting lifestyle and performance for movement, adaptability and zone based training. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261026029587/en/ WHOOP and Samuel Ross MBE Unveil Layer 2 of PROJECT TERRAIN While the first PROJECT TERRAIN collection harnessed dense cities and modern training grounds, Layer 2 explores performance through material, silhouette and tactility. Drawing on the textures, conditions, and flux of the natural world, the collection introduces a newly developed system of WHOOP bands, Italian technical apparel, outerwear, and accessories designed to move between urban and outdoor settings. Performance extends be
Bleeding gums? Don't ignore the warning signs – the first stage of gum disease can be reversed26.10.2026 12:28:00 EET | Press release
Gums bleeding when brushing can happen to any of us, and it is easy to ignore. But blood in the sink is a sign that something is not right with your mouth. Bleeding gums often indicate gingivitis, the earliest and most common form of gum disease. The good news: gingivitis can be reversed with proper oral hygiene. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022835650/en/ Oral-B iO Left untreated, gingivitis can progress into periodontitis, a more severe stage of gum disease that can only be managed, not reversed, and can lead to losing teeth over time. Healthy gums matter beyond the mouth, too. Oral health and systemic health are deeply interconnected, with inflammation and bacteria from oral diseases contributing to conditions such as heart disease, diabetes and dementia. "Gums bleeding when brushing can happen to any of us. When they do, it shouldn't be ignored," said Eva Castro Perea, who holds a degree in dentistry
Merz Therapeutics Presents New Phase 2 PaiNT Data in Peripheral Neuropathic Pain at IASP 202626.10.2026 09:00:00 EET | Press release
Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced the presentation of new clinical and translational research in peripheral neuropathic pain (PNP) at the International Association for the Study of Pain (IASP) 2026 World Congress in Bangkok, Thailand, taking place from 26 to 30 October. The research spans new Phase 2 findings on incobotulinumtoxinA in postherpetic neuralgia (PHN) and post-surgical/post-traumatic neuropathic pain (PS/PTNP), as well as preclinical studies exploring potential biological mechanisms involved in effects of incobotulinumtoxinA on PNP models, highlighting Merz Therapeutics’ growing presence in neuropathic pain. In the PHN population of the Phase 2 PaiNT trial, results over 20 weeks favored incobotulinumtoxinA versus placebo treatment. In an exploratory analysis of average daily pain (ADP) intensity, the greatest difference between treatment groups was observed at Week 6 (adjusted mean difference, −1.14 points; p=0.0488).
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom